Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Down 5% After Analyst Downgrade

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH – Get Rating) (TSE:AUP)’s stock price fell 5% during mid-day trading on Tuesday after SVB Leerink lowered their price target on the stock from $30.00 to $22.00. SVB Leerink currently has an outperform rating on the stock. Aurinia Pharmaceuticals traded as low as $9.98 and last traded at $10.14. 220,268 shares […]

Related Keywords

China ,Japan ,Canada ,Thomson Reuter ,Jill Leversage ,Selective Wealth Management Inc ,Aurinia Pharmaceuticals Inc ,Zacks Investment Research ,Capital Group ,Nasdaq ,Lazard Asset Management ,Jefferies Financial Group ,Aurinia Pharmaceuticals Company Profile ,Otsuka Pharmaceutical Co Ltd ,Aurinia Pharmaceuticals ,Macquarie Group Ltd ,Royal Bank ,Get Rating ,Financial Group ,Investment Research ,Director Jill Leversage ,Wealth Management ,Asset Management ,Private Capital Group ,Pharmaceuticals Company Profile ,Pharmaceuticals Inc ,Nasdaq Auph ,Auph ,Medical ,Stocks ,Technicals ,